Comprehensive Transcriptomic Analysis of VISTA in Acute Myeloid Leukemia: Insights into Its Prognostic Value

Keyphrases

• Acute Myeloid Leukemia 100%
• Prognostic Value 100%
• Transcriptome Analysis 100%
• V-domain Ig Suppressor of T Cell Activation 100%
• Leukemia Patients 50%
• Working Diagnosis 25%
• Recurrent Disease 25%
• Leukemia Cell Lines 25%
• NPM1 mutation 25%
• Whole Exome Sequencing 12%
• T Cells 12%
• MRNA Level 12%
• Disease Onset 12%
• Leukemia Cells 12%
• Bone Marrow 12%
• Healthy Individuals 12%
• Leukemia 12%
• Hematopoietic Stem Cells 12%
• Myeloid Differentiation 12%
• Strong Correlation 12%
• Conventional Chemotherapy 12%
• Expression Level 12%
• Negative Regulator 12%
• Treatment Resistance 12%
• Myelomonocytic 12%
• Publicly Available 12%
• Chemotherapy Regimen 12%
• Myeloid Malignancies 12%
• FMS-like Tyrosine Kinase 3 (FLT3) 12%
• Acute Myeloid Leukemia Cells 12%
• Disease Treatment 12%
• Single-cell RNA Sequencing (scRNA-seq) 12%
• Immune Escape 12%
• Antitumor Immune Response 12%
• Targeted Therapeutics 12%
• Normal Karyotype 12%
• Normal Hematopoiesis 12%
• Immune Parameters 12%
• Current Diagnostics 12%
• Pharmacological Targets 12%
• Long-term Remission 12%
• Diagnostic Scheme 12%
• Monocytic Differentiation 12%
• Immune Checkpoint Regulator 12%

Medicine and Dentistry

• Gene Expression Profiling 100%
• T Cell Activation 100%
• Acute Myeloid Leukemia 100%
• Immunoglobulin Domain 100%
• Immunity 37%
• Recurrent Disease 25%
• NPM1 25%
• Diagnosis 12%
• RNA Sequence 12%
• Immune Response 12%
• Immunotherapy 12%
• Leukemia Cell 12%
• Combination Therapy 12%
• T Cell 12%
• Myeloid Differentiation 12%
• Hematopoiesis 12%
• Myeloid Malignancy 12%
• Leukemia 12%
• Exome Sequencing 12%
• Pharmacological Target 12%
• Leukemia Cell Line 12%
• Karyotype 12%
• Acute Myeloid Leukemia Cell Line 12%
• Chemotherapy 12%
• Messenger RNA 12%
• Hematopoietic Cell 12%
• Diseases 12%

Immunology and Microbiology

• T Cell Activation 100%
• Myeloid 100%
• Immunoglobulin Domain 100%
• Gene Expression Assay 100%
• Immunity 22%
• Hematopoietic Cell 11%
• T Cell 11%
• Immune Response 11%
• Myeloid Differentiation 11%
• Immunotherapy 11%
• RNA Sequence 11%
• Leukemia Cell 11%
• Whole Exome Sequencing 11%
• Hematopoiesis 11%
• Immune Escape 11%
• Leukemia Cell Line 11%
• mRNA Expression Level 11%
• Karyotype 11%
• Acute Myeloid Leukemia Cell Line 11%